Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Drug Chem Toxicol ; 39(3): 312-21, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26739110

RESUMEN

CONTEXT: Celtis glabrata is used in Turkey for the treatment of various health disorders. OBJECTIVE: The acetone, chloroform, ethanol, and methanol extracts of C. glabrata leaf, fruit, and seed were investigated to evaluate their antimutagenic activities. MATERIAL AND METHODS: The antimutagenicity of these extracts was determined by Ames test against mutagens (4-nitro-O-phenylenediamine, 2-aminofluorene (2-AF), and sodium azide (SA)). The extracts were used at concentrations between 5 and 0.005 mg/plate. RESULTS: The ethanol extracts of leaves exhibited strong antimutagenicity (70%) against 2-AF with S9 at 5 mg/plate on TA98. But methanol (61%, 53%) and acetone (53%, 52%) also revealed strong inhibition rates at concentrations of ≥ 0.5 mg/plate. Among the extracts, the highest activity (96%) was obtained from acetone extract against SA without S9, followed by chloroform extract (91%) at a dose of 5 mg/plate on TA100 with S9. Ethanol (without S9) and chloroform (with S9) extracts showed strong antimutagenicity at all doses. Exception of chloroform and acetone (without S9), all fruit extracts (with/without S9) manifested strong antimutagenicity at doses of ≥ 0.5 mg/plate on TA98 strain. Ethanol extracts revealed 68% inhibition against 2-AF on TA98. Acetone and ethanol extracts manifested 84% and 82% inhibition against SA on TA100, respectively. All the extracts of seeds revealed strong inhibition against 2-AF at ≥ 0.5 mg/plate doses on TA98, but acetone extract showed excellent antimutagenicity (94%). Moreover, the chloroform (74, 73, 63, 54%), acetone (74, 72, 70, 65%) and methanol (74, 67, 63, 61%) extracts of seeds revealed strong antimutagenic activity on TA100 against SA with S9. DISCUSSION AND CONCLUSION: This plant may be natural source of antimutagenic agents.


Asunto(s)
Antimutagênicos/farmacología , Disparidad de Par Base/efectos de los fármacos , Cannabaceae/química , Mutación del Sistema de Lectura/efectos de los fármacos , Extractos Vegetales/farmacología , Salmonella typhimurium/efectos de los fármacos , Antimutagênicos/envenenamiento , Frutas/química , Mutágenos/toxicidad , Extractos Vegetales/aislamiento & purificación , Hojas de la Planta/química , Salmonella typhimurium/genética , Semillas/química
2.
Phytother Res ; 23(10): 1378-84, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19277970

RESUMEN

Silymarin, a polyphenolic flavonoid isolated from milk thistle (Silybum marianum), is being used clinically in Europe and Asia for the treatment of liver diseases. Silymarin has a strong antioxidative action capable of scavenging both free radicals and reactive oxygen species responsible for cancer. Silymarin, a powerful hepatoprotective and antioxidant, was chosen in the present study and was tested for its antimutagenic activity using an in vitro test, the Ames bacterial reverse mutation assay. The results indicated that silymarin showed a significant mutagenicity in frame shift mutant strains (TA97a and TA98) with metabolic activation. This compound also showed stronger antimutagenic effect against 2-aminofluorene and 4-nitroquinoline N-oxide induced mutation. When pre-, co- and post-treatment of silymarin was carried out, it showed stronger antimutagenic activity in the post-treatment with 2-aminofluorene and 4-nitroquinoline N-oxide in TA97a and TA98 strains.


Asunto(s)
Antimutagênicos/farmacología , Antineoplásicos Fitogénicos/farmacología , Mutágenos/farmacología , Neoplasias/prevención & control , Extractos Vegetales/farmacología , Silybum marianum/química , Silimarina/farmacología , 4-Nitroquinolina-1-Óxido , Animales , Antimutagênicos/efectos adversos , Antimutagênicos/uso terapéutico , Antineoplásicos Fitogénicos/efectos adversos , Antineoplásicos Fitogénicos/uso terapéutico , Antioxidantes/efectos adversos , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Flavonoides/efectos adversos , Flavonoides/farmacología , Flavonoides/uso terapéutico , Fluorenos , Mutación del Sistema de Lectura/efectos de los fármacos , Frutas , Masculino , Pruebas de Mutagenicidad/métodos , Neoplasias/genética , Fenoles/farmacología , Extractos Vegetales/efectos adversos , Extractos Vegetales/uso terapéutico , Polifenoles , Ratas , Ratas Wistar , Salmonella typhimurium , Semillas , Silimarina/efectos adversos , Silimarina/uso terapéutico
3.
Mutat Res ; 638(1-2): 1-10, 2008 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-17900630

RESUMEN

Selenium (Se) is an essential trace element for humans, animals and some bacteria which is important for many cellular processes. Se's bio-activity is mainly influenced by its chemical form and dose. The use of Se supplements in the human diet emphasizes the need to establish both the beneficial and detrimental doses of each Se compound. We have evaluated three different Se compounds, sodium selenite (SeL), selenomethionine (SeM) and Se-methylselenocysteine (SeMC), with respect to their potential DNA damaging effects. The budding yeast Saccharomyces cerevisiae was used as a model system to test the toxic and mutagenic effects as well as the DNA double-strand breakage potency of these Se compounds in both exponentially growing and stationary yeast cells. Only SeL manifested any significant toxic effects in the yeast which were more pronounced in the exponentially growing cells than in those cells in the stationary phase of growth. The toxic effects of SeL were however accompanied with the pro-mutagenic effects in the stationary cell phase of growth. The toxic and mutagenic effects of SeL are likely associated with the ability of this compound to generate DNA double-strand breaks (DSB). We also show that SeL significantly increased frame-shift mutations, especially 1-4 bp deletions, in the CAN1 mutational spectrum of the yeast genome when compared to untreated control. We propose that SeL is acting as an oxidizing agent in S. cerevisiae producing superoxide and oxidative damage to DNA accounting for the observed DSB and cell death.


Asunto(s)
ADN de Hongos/efectos de los fármacos , Mutágenos/toxicidad , Saccharomyces cerevisiae/efectos de los fármacos , Compuestos de Selenio/toxicidad , Secuencia de Bases , División Celular , Supervivencia Celular/efectos de los fármacos , Mutación del Sistema de Lectura/efectos de los fármacos , Datos de Secuencia Molecular , Pruebas de Mutagenicidad
4.
Pharmazie ; 56(5): 412-4, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11400559

RESUMEN

Eupatorium inulaefolium is used as an antimalarial agent by traditional healers of the Tumaco region (Nariño-Colombia). Several extracts of this plant have been tested by our laboratory and in vitro antimalarial activity against the FCB-2 strain of Plasmodium falciparum has been confirmed. For this reason, the mutagenic effect of the methanol, dichloromethane, and hexane extracts of Eupatorium inulaefolium (number 83377 university of Antioquia herbarium) were evaluated using the Ames test. None of the extracts evaluated had mutagenic effects on TA-98 or TA-100 strains of Salmonella typhimurium.


Asunto(s)
Antimaláricos/toxicidad , Mutágenos/toxicidad , Plantas Medicinales/química , Animales , Disparidad de Par Base/efectos de los fármacos , ADN Bacteriano/efectos de los fármacos , ADN Bacteriano/genética , Mutación del Sistema de Lectura/efectos de los fármacos , Técnicas In Vitro , Masculino , Pruebas de Mutagenicidad , Extractos Vegetales/toxicidad , Ratas , Salmonella typhimurium/efectos de los fármacos , Salmonella typhimurium/genética , Solventes , Fracciones Subcelulares/efectos de los fármacos , Fracciones Subcelulares/enzimología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA